Metabolic imaging with Gallium-68 citrate PET and 3D MRSI in patients with glioma
Yan Li1, Spencer Behr1, Susan Chang2, Sarah J Nelson1, and Michael Evans1
1Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA, United States, 2Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, United States
study evaluated the feasibility of using combined metabolic imaging
methodologies, namely 3D lactate-edited proton magnetic resonance spectroscopic
imaging and Gallium-68 citrate PET, in patients with glioma using a PET/MR
This abstract and the presentation materials are available to members only;
a login is required.